DORAVIRINE,
MK-1439,
Doravirine,
1338225-97-0,
MK-1439,
MK1439,
UNII-913P6LK81M,
913P6LK81M,
3-chloro-5-[1-[(4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methyl]-2-oxo-4-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile,
MK 1439,
3-Chloro-5-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)benzonitrile,
3-Chloro-5-({1-[(4-Methyl-5-Oxo-4,5-Dihydro-1h-1,2,4-Triazol-3-Yl)methyl]-2-Oxo-4-(Trifluoromethyl)-1,2-Dihydropyridin-3-Yl}oxy)benzonitrile,
Doravirine [USAN:INN],
4ncg,
Doravirine; MK-1439,
MK-1439(Doravirine),
Doravirine (MK-1439),
Doravirine (JAN/USAN/INN),
SCHEMBL2509885,
CHEMBL2364608,
DTXSID30158386,
ZIAOVIPSKUPPQW-UHFFFAOYSA-N,
BCP02296,
EX-A1968,
MFCD22417167,
ZINC72317283,
AKOS030528603,
CS-5924,
DB12301,
SB17104,
HY-16767,
D10624,
S900006160,
2KW,
3-chloro-5-[[1-[(4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methyl]-2-oxo-4-(trifluoromethyl)-3-pyridyl]oxy]benzonitrile,
Benzonitrile, 3-chloro-5-((1-((4,5-dihydro-4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methyl)-1,2-dihydro-2-oxo-4-(trifluoromethyl)-3-pyridinyl)oxy)-,
Doravirine [USAN],
D0R0TS,
A12443,